Zydus Lifesciences Shares Climb After Final Ammonium Lactate Cream Approval

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Zydus Lifesciences Shares Surge on USFDA Approval for Ammonium Lactate Cream

Zydus Lifesciences

M

Moneycontrol•16-02-2026, 09:23

Zydus Lifesciences Shares Surge on USFDA Approval for Ammonium Lactate Cream

•Zydus Lifesciences received final USFDA approval for its Ammonium Lactate Cream, 12%.
•The cream treats dry, scaly skin (xerosis) and ichthyosis vulgaris, moisturizing and softening skin.
•Manufactured at Changodar, Ahmedabad, and distributed by Viona Pharmaceuticals Inc.
•Zydus has 430 approvals and filed 505 ANDAs since FY 2003-04.
•Company settled a patent dispute with Astellas Pharma for $120 million regarding Mirabegron.

Read Full Article on Moneycontrol in English

✦

More like this

✦

More like this

Zydus Lifesciences Secures USFDA Approval for Ammonium Lactate Cream

Zydus Lifesciences Secures USFDA Approval for Ammonium Lactate Cream

Representational image (Image: News18)

Zydus to Pay Astellas $120 Million to Settle Patent Dispute Over Bladder Drug

At previous close, the Sensex was down -40.28 points (-0.05 percent) at 84,233.64, and the Nifty was up 18.70 points (0.07 percent) at 25,953.85

Zydus Lifesciences Shares Jump 2.21% in Early Trade Amidst Strong Financials

The announcement comes days after local peer Lupin decided to settle its dispute with Astellas over the same drug for $90 million. Reuters

Zydus Life Settles Astellas Bladder Drug Patent Dispute for $120 Million

Zydus Life Soars: Ahmedabad Unit Clears USFDA Inspection with Zero Observations

Zydus Life Soars: Ahmedabad Unit Clears USFDA Inspection with Zero Observations

Accumulate

Prabhudas Lilladher Recommends Accumulate on Zydus Lifesciences, Target Rs 1020